Analyst Ratings for Sonnet BioTherapeutics (SONN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/27/2023 | Ladenburg Thalmann | Ahu Demir | New Coverage | Buy (N/A) |
7.00 (N/A) |
1.41 (1.26) |
-10.64% | Details |
| 12/16/2021 | H.C. Wainwright | Mike King | New Coverage | Buy (N/A) |
2.00 (N/A) |
0.50 (1.26) |
152% | Details |
 |
||||||||
|
||||||||
